SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital (APLD) is trending after NVIDIA's recent 13F filing revealed an exit from its stake, leading many in the community to debate if the subsequent sell-off is an overreaction. Investors are emphasizing APLD's ongoing AI infrastructure buildouts and substantial long-term contracts, particularly with NVIDIA-backed CoreWeave, as unchanged fundamentals driving future growth.

WorldFinancial

WorldFinancial (WLFI) is trending due to anticipation of significant announcements from a high-profile forum, driving bullish community discussions around its foreign exchange platform and potential institutional adoption. This excitement is balanced by ongoing scrutiny regarding its foreign investments and accusations of insider activity, leading to divided community sentiment.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is trending after its recent earnings report showed robust revenue growth and increased guidance, yet a lowered EPS outlook fueled by acquisition-related costs sparked a sell-off. The community is debating if this is an overreaction stemming from broader software sector concerns and high valuations, or a logical repricing, even as many see long-term buying opportunities due to cybersecurity's non-discretionary nature and platform consolidation trends.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is drawing significant attention as its community eagerly awaits the SuperApp launch and the final token unlock, with robust discussion around its ISO/MiCA compliance and potential for revolutionizing real-world payments, prompting many to actively accumulate during market dips.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera (ATOM) is seeing explosive trading volume and sparking intense debate among investors, fueled by recent indications of its MST technology achieving significant power reductions for AI chips and progress in Gate-All-Around (GAA) applications. The community is split, with bulls anticipating imminent licensing deals with major semiconductor players, while skeptics warn of a potential "pump and dump" given the company's history of low revenue and prior disappointments.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion Inc. ($INFQ) is trending after completing its SPAC merger and beginning trading, with a strong community reaction to its CEO's CNBC interview and upcoming NYSE bell ringing. Investors are highly optimistic about its neutral-atom quantum technology, highlighting partnerships with NVIDIA and NASA, and contrasting its revenue-generating sensing products and defense contracts favorably against other quantum sector players.

QuickLogic Corp. operates as a semiconductor company, which designs, markets, and supports primarily Customer Specific Standard Products and secondarily, Field Programmable Gate Arrays, sensor software algorithms, software drivers, associated design software and programming hardware. It develops and markets low power customizable semiconductor and software algorithm solutions that enable customers to differentiate their products by adding new features, extending battery life, becoming more contextually aware and improving the visual experience with their mobile, consumer and enterprise products. The company was founded by John M. Birkner, Andrew K. Chan, and Hua-Thye Chua in 1988 and is headquartered in San Jose, CA.

Quicklogic Corp

QuickLogic is trending due to the launch of its Physical AI Chiplet Ecosystem (PACE) and significant advancements with its eFPGA technology on Intel's cutting-edge 18A process node. The community is keenly observing the company's unique position in providing advanced, radiation-hardened solutions for defense and commercial chiplet markets, with substantial contract awards anticipated to drive future growth despite recent short-term revenue shifts.

Cadence Design Systems, Inc. engages in the provision of design and development of integrated circuits and electronic devices. It operates through the following geographical segments: Americas, Asia, EMEA, and Japan. The company was founded by Alberto Sangiovanni-Vincentelli, Gudmundur A. Hjartarson, K. Bobby Chao, and K. Charles Janac in June 1988 and is headquartered in San Jose, CA.

Cadence Design Systems, Inc.

Cadence Design Systems is trending following its strong Q4 earnings beat and record backlog, with community discussion focused on its conservative FY26 guidance despite its pivotal role in AI-driven chip design.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending as Meta expands its multiyear deal to deploy millions of AI chips, cementing NVIDIA's market leadership while fueling intense community debate around its valuation and upcoming earnings performance.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending with high anticipation for its upcoming Investor Day, following a recent FDA Fast Track designation for its PPP program and significant institutional accumulation. The community is actively discussing the stock's perceived undervaluation, potential for a short squeeze, and persistent buyout speculation, all driven by confidence in its nanobody platform's superior science.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Spyre Therapeutics (NASDAQ:SYRE) Trading Up 8.5% - Should You Buy?

Spyre Therapeutics (NASDAQ:SYRE) Stock Price Up 8.5% - Here's What Happened...

Spyre Therapeutics, Inc. $SYRE Shares Acquired by Candriam S.C.A.

Candriam S.C.A. boosted its stake in shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE - Free Report) by 64.4% in the third quarter, according to its most recent filing with the Securities and Exchange...

Spyre Therapeutics (NASDAQ:SYRE) Hits New 52-Week High - Here's What Happened

Spyre Therapeutics (NASDAQ:SYRE) Hits New 12-Month High - Still a Buy...

Spyre Therapeutics (NASDAQ:SYRE) CEO Sells $492,000.00 in Stock

Spyre Therapeutics, Inc. (NASDAQ:SYRE - Get Free Report) CEO Cameron Turtle sold 15,000 shares of the firm's stock in a transaction that occurred on Monday, February 2nd. The shares were sold at an...

Spyre Therapeutics, Inc. (NASDAQ:SYRE) Sees Significant Decrease in Short Interest

Spyre Therapeutics, Inc. (NASDAQ:SYRE - Get Free Report) saw a significant drop in short interest in the month of January. As of January 15th, there was short interest totaling 10,069,741 shares, a...

Spyre Therapeutics (NASDAQ:SYRE) Receives "Buy" Rating from BTIG Research

BTIG Research reissued a "buy" rating and set a $70.00 target price on shares of Spyre Therapeutics in a report on Friday...

Spyre Therapeutics (NASDAQ:SYRE) Trading 7.7% Higher - What's Next?

Spyre Therapeutics (NASDAQ:SYRE) Trading 7.7% Higher - Here's What Happened...

Spyre Therapeutics (NASDAQ:SYRE) CEO Sells $460,200.00 in Stock

Spyre Therapeutics, Inc. (NASDAQ:SYRE - Get Free Report) CEO Cameron Turtle sold 15,000 shares of the company's stock in a transaction dated Friday, January 2nd. The stock was sold at an average...

Insider Selling: Spyre Therapeutics (NASDAQ:SYRE) CEO Sells 15,000 Shares of Stock

Spyre Therapeutics, Inc. (NASDAQ:SYRE - Get Free Report) CEO Cameron Turtle sold 15,000 shares of the firm's stock in a transaction on Friday, January 2nd. The shares were sold at an average price of...

Spyre Therapeutics (NASDAQ:SYRE) Shares Down 6.5% - Time to Sell?

Spyre Therapeutics (NASDAQ:SYRE) Shares Down 6.5% - What's Next...

Spyre Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product, Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency. The company was founded by George Georgiou and David G. Lowe on December 16, 2013 and is headquartered in Waltham, MA.

Spyre Therapeutics Inc.

Fundamental

Technical

A mix of both

Some investors focus on company fundamentals like earnings, growth, and valuation. Others rely on price action, trends, and momentum. Many use a combination of both to guide their decisions. What do you use?

What type of analysis drives your investment decisions?

SYRE
Aeglea BioTherapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SYRE News

SYREAeglea BioTherapeutics Inc